The peptide conversation is shifting. Secretary RFK Jr. recently announced that the FDA plans to move 14 peptides from Category 2 back to Category 1 restoring FDA recognized status and making them Orthopedic Use of BPC 157 Sports Med Review FDA considers adding a dozen peptides to its bulk drug compounding list RAPS FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner Are Peptides coming off of the FDA Category 2 list? A legal breakdown. FDA Peptide Reclassification 2026: What It Means for Providers